Search Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupGastroenterologic OncologyRegional therapyDiseaseHepatocellular CarcinomaSubgroupICD10C22.0MeSHCarcinoma, HepatocellularLiver NeoplasmsSequenceChemotherapyChemo-substanceCisplatinDoxorubicinDrug-Eluting BeadsEthiodized oilIodixanolMitomycinNaCl 0.9%Polyvinyl alcoholChemo-substanceCisplatinDoxorubicinDrug-Eluting BeadsEthiodized oilIodixanolMitomycinNaCl 0.9%Polyvinyl alcoholChemo-substanceCisplatinDoxorubicinDrug-Eluting BeadsEthiodized oilIodixanolMitomycinNaCl 0.9%Polyvinyl alcoholChemo-substanceCisplatinDoxorubicinDrug-Eluting BeadsEthiodized oilIodixanolMitomycinNaCl 0.9%Polyvinyl alcoholNo. Substances235 RadiotherapySupportive therapySupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesiumMagnesium sulfatePotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesiumMagnesium sulfatePotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesiumMagnesium sulfatePotassium chlorideSupportive substanceBalanced Crystalloid SolutionDexamethasoneFosaprepitantGranisetronMagnesiumMagnesium sulfatePotassium chlorideNo. Substances37Protocol classificationTherapy classificationalternativecurrent standardIntensityStandard doseTherapy indicationseveral possibleTherapy phaseTherapy intentionpalliativeRisksEmetogenicityEmetogenicity (MASCC/ESMO) only studiesPublicationAuthorCho SFohlen ALammer JLencioni RYamada RDiseaseHepatozelluläres KarzinomHepatozelluläres Karzinom, größer 5cm, Zweitlinie nach DEB-TACE mit HepaspheresNicht resezierbares, nicht-metastasiertes hepatozelluläres KarzinomNicht resezierbares, nicht-metastasiertes hepatozelluläres Karzinom, Erstlinie, ECOG 0-1OriginAsan Medical Center, Department of Radiology, University of Ulsan College of Medicine, Seoul, KoreaCardiovascular and Interventional Radiology, Medical University Vienna, Austria, PRECISION V StudyDepartment of Interventional and Diagnostic Imaging, University Hospital of Caen, FranceDivision of Diagnostic Imaging and Intervention, Pisa University Hospital, University of PisaDivision of Vascular and Interventional Radiology, Department of Radiology, Medical University of South Carolina, Charleston, SC, USAProtocols in Revision 5 protocols foundProtocols under revision.cTACE - Cisplatin 2 / Ethiodized oil 12.8, Hepatocellular Carcinoma (PID2879 V1.0)cTACE - Doxorubicin 100 / Ethiodized oil 12.8, Hepatocellular Carcinoma (PID2932 V1.0)cTACE - Mitomycin 10 / Ethiodized oil 6.4, Hepatocellular Carcinoma (PID2866 V1.0)DEB-TACE - Doxorubicin 100, Hepatocellular Carcinoma (PID2880 V1.0)DEB-TACE - Doxorubicin 75, Hepatocellular Carcinoma (PID2931 V1.0)
